115 related articles for article (PubMed ID: 9491899)
1. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis.
Sarnatskaya VV; Ivanov AI; Nikolaev VG; Rotellar E; von Appen K; Haspar M; Maslenny VN; Klinkmann H
Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899
[TBL] [Abstract][Full Text] [Related]
2. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
[TBL] [Abstract][Full Text] [Related]
3. Impairments of the biological properties of serum albumin in patients on haemodialysis.
Lim PS; Cheng YM; Yang SM
Nephrology (Carlton); 2007 Feb; 12(1):18-24. PubMed ID: 17295656
[TBL] [Abstract][Full Text] [Related]
4. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
7. Global fibrinolytic capacity in children on dialysis.
Agras PI; Baskin E; Cengiz N; Kirazli S; Saatci U; Ozbek N
Thromb Res; 2005; 115(3):185-9. PubMed ID: 15617740
[TBL] [Abstract][Full Text] [Related]
8. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
[TBL] [Abstract][Full Text] [Related]
9. [Modification of the ligand load and structure of human serum albumin with different methods of isolation].
Ivanov AI; Sarnatskaia VV; Korolenko EA; Korolik EV; Meleshchenko LA; Nikolaev VG; Nikolaĭchik VV; Iushko LA; Zhbankov RG
Biokhimiia; 1996 May; 61(5):903-11. PubMed ID: 8754273
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
11. Biophysical characterization of albumin preparations from blood serum of healthy donors and patients with renal diseases. Part I: spectrofluorometric analysis.
Parkhomenko TV; Klicenko OA; Shavlovski MM; Kuznetsova IM; Uversky VN; Turoverov KK
Med Sci Monit; 2002 Jul; 8(7):BR261-5. PubMed ID: 12118188
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk markers in hemodialysis].
Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
[TBL] [Abstract][Full Text] [Related]
13. Plasma protein carbonylation in chronic uremia.
Pavone B; Sirolli V; Giardinelli A; Bucci S; Forlì F; Di Cesare M; Sacchetta P; Di Pietro N; Pandolfi A; Urbani A; Bonomini M
J Nephrol; 2011; 24(4):453-64. PubMed ID: 21607919
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection.
Tseng GY; Lin HJ; Fang CT; Cheng YT; Huang CH; Tseng GC; Wang PC; Hung TL; Deng YC; Tsai CC; Yang KY
Ren Fail; 2008; 30(10):1000-5. PubMed ID: 19016152
[TBL] [Abstract][Full Text] [Related]
15. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
18. [Renal replacement therapy by hemodialysis: an overview].
Jacobs C
Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
[TBL] [Abstract][Full Text] [Related]
19. Oxidative modifications impair albumin quantification.
Michelis R; Kristal B; Snitkovsky T; Sela S
Biochem Biophys Res Commun; 2010 Oct; 401(1):137-42. PubMed ID: 20833127
[TBL] [Abstract][Full Text] [Related]
20. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
Soejima A; Matsuzawa N; Miyake N; Karube M; Fukuoka K; Nakabayashi K; Kitamoto K; Nagasawa T
Clin Nephrol; 1999 Feb; 51(2):92-7. PubMed ID: 10069644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
